MEI Pharma Inc.
0JW9StockLSE
$0.76 ▲ +8.27%
12 juin 2026
0
MEI Pharma Inc.
$0.76 ▲ +8.27%
12 juin 2026
0JW9StockLSE

01 / À propos

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

Arberion
Loading market data